Jungmin Choi
Jungmin Choi
Associate Professor of Biomedical Sciences, Korea University
Verified email at - Homepage
Cited by
Cited by
Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer
S Gettinger, J Choi, K Hastings, A Truini, I Datar, R Sowell, A Wurtz, ...
Cancer discovery 7 (12), 1420-1435, 2017
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
KA Schalper, ME Rodriguez-Ruiz, R Diez-Valle, A López-Janeiro, ...
Nature medicine 25 (3), 470-476, 2019
Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening
BD Stuart, J Choi, S Zaidi, C Xing, B Holohan, R Chen, M Choi, ...
Nature genetics 47 (5), 512-517, 2015
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
K Hastings, HA Yu, W Wei, F Sanchez-Vega, M DeVeaux, J Choi, H Rizvi, ...
Annals of Oncology 30 (8), 1311-1320, 2019
Expression analysis and significance of PD-1, LAG-3, and TIM-3 in human non–small cell lung cancer using spatially resolved and multiparametric single-cell analysis
I Datar, MF Sanmamed, J Wang, BS Henick, J Choi, T Badri, W Dong, ...
Clinical Cancer Research 25 (15), 4663-4673, 2019
CLCN2 chloride channel mutations in familial hyperaldosteronism type II
UI Scholl, G Stölting, J Schewe, A Thiel, H Tan, C Nelson-Williams, ...
Nature genetics 50 (3), 349-354, 2018
Isolated polycystic liver disease genes define effectors of polycystin-1 function
W Besse, K Dong, J Choi, S Punia, SV Fedeles, M Choi, AR Gallagher, ...
The Journal of clinical investigation 127 (5), 1772-1785, 2017
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition
S Zhao, S Bellone, S Lopez, D Thakral, C Schwab, DP English, J Black, ...
Proceedings of the National Academy of Sciences 113 (43), 12238-12243, 2016
Two locus inheritance of non-syndromic midline craniosynostosis via rare SMAD6 and common BMP2 alleles
AT Timberlake, J Choi, S Zaidi, Q Lu, C Nelson-Williams, ED Brooks, ...
elife 5, e20125, 2016
Regression of chemotherapy-resistant polymerase ϵ (POLE) ultra-mutated and MSH6 hyper-mutated endometrial tumors with nivolumab
AD Santin, S Bellone, N Buza, J Choi, PE Schwartz, J Schlessinger, ...
Clinical Cancer Research 22 (23), 5682-5687, 2016
Transcriptome Remodeling in Trypanosoma cruzi and Human Cells during Intracellular Infection
Y Li, S Shah-Simpson, K Okrah, AT Belew, J Choi, KL Caradonna, ...
PLoS pathogens 12 (4), e1005511, 2016
A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers
SN Gettinger, J Choi, N Mani, MF Sanmamed, I Datar, R Sowell, VY Du, ...
Nature communications 9 (1), 3196, 2018
De novo mutation in genes regulating neural stem cell fate in human congenital hydrocephalus
CG Furey, J Choi, SC Jin, X Zeng, AT Timberlake, C Nelson-Williams, ...
Neuron 99 (2), 302-314. e4, 2018
Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling
JM Chan, S Zaidi, JR Love, JL Zhao, M Setty, KM Wadosky, A Gopalan, ...
Science 377 (6611), 1180-1191, 2022
De novo mutations in inhibitors of Wnt, BMP, and Ras/ERK signaling pathways in non-syndromic midline craniosynostosis
AT Timberlake, CG Furey, J Choi, C Nelson-Williams, ...
Proceedings of the National Academy of Sciences 114 (35), E7341-E7347, 2017
Comprehensive genetic analysis of follicular thyroid carcinoma predicts prognosis independent of histology
NG Nicolson, TD Murtha, W Dong, JO Paulsson, J Choi, AL Barbieri, ...
The Journal of Clinical Endocrinology & Metabolism 103 (7), 2640-2650, 2018
Targeted mutagenesis in mouse cells and embryos using an enhanced prime editor
SJ Park, TY Jeong, SK Shin, DE Yoon, SY Lim, SP Kim, J Choi, H Lee, ...
Genome biology 22 (1), 170, 2021
Mutations in chromatin modifier and ephrin signaling genes in vein of Galen malformation
D Duran, X Zeng, SC Jin, J Choi, C Nelson-Williams, B Yatsula, J Gaillard, ...
Neuron 101 (3), 429-443. e4, 2019
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy
L Zammataro, S Lopez, S Bellone, F Pettinella, E Bonazzoli, E Perrone, ...
Proceedings of the National Academy of Sciences 116 (45), 22730-22736, 2019
Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo
G Foggetti, C Li, H Cai, JA Hellyer, WY Lin, D Ayeni, K Hastings, J Choi, ...
Cancer discovery 11 (7), 1736-1753, 2021
The system can't perform the operation now. Try again later.
Articles 1–20